GlaxoSmithKline Pharmaceuticals Share Price
Mid Cap | Pharmaceuticals and health care | NSE: GLAXO | BSE: 500660
₹2,739.25 
-117.50 (-4.11 %)
Last Updated: 04 Apr 2025 03:54 PM
BULLISH
Overview
Open (₹) 2,856.75
High (₹) 2,870.95
Low (₹) 2,704.60
Prev. Close (₹) 2,856.75
Volume 1,03,973
VWAP (₹) 2,502.54
ROCE (%) 47.33
Industry P/E 44.73
TTM P/E 54.01
P/B Ratio 26.11
Market Cap (₹) Cr.46,404.55
Dividend Yield (%)1.17
EPS (₹) 34.83
ROE33.19%
Sales Growth (%) 6.21
Profit Growth (%)-3.39
Day Range
2,870.952,870.95
52 Week Range
1,825.053,087.95
Historical Returns
Returns (6M)
4.82 %
Returns (1Y)
41.34 %
Returns (3Y)
67.93 %
Returns (5Y)
119.4 %
Returns (6M)
4.82 %
Returns (1Y)
41.34 %
Returns (3Y)
67.93 %
Returns (5Y)
119.4 %
SWOT Analysis
- Effectively using its capital to generate profits - ROCE improved in the last year
- Company with no debt
- Strong short-term momentum: Price above short-term moving averages (EMA_10)
- Strong long-term momentum: Price above long-term moving averages (EMA_200)
- Bullish MACD crossover (12,6,9) indicates potential upward price movement.
- Positive ROC (9) indicates upward momentum.
- Strong trend indicated by ADX above 25.
- Price above the pivot point indicates bullish sentiment.
- Price above EMA and SMA (50) indicates bullish momentum.
Technicals
Technical Rating
BULLISHRSI 66.86
MFI 83.16
ATR 156.94
Commodity Channel Index 70.77
ROC125 -10.53
ROC21 25.01
Williams %R -34.70
Resistance & Support
| Type | Resistance 1 | Resistance 2 | Resistance 3 | PP | Support 1 | Support 2 | Support 3 |
|---|---|---|---|---|---|---|---|
| Current | 2,555.29 | 2,635.22 | 2,685.34 | 2,505.17 | 2,425.24 | 2,375.12 | 2,295.19 |
| Week Ago | 2,569.14 | 2,629.57 | 2,669.14 | 2,529.57 | 2,469.14 | 2,429.57 | 2,369.14 |
| Month Ago | 2,073.36 | 2,123.58 | 2,169.71 | 2,027.23 | 1,977.01 | 1,930.88 | 1,880.66 |
EMA & SMA
2739.25
Current Price
Bullish Moving Averages
20
Bearish Moving Averages
0
5 Day 2543.58
9 Day 2491.03
10 Day 2394.09
12 Day 2329.02
14 Day 2328.72
20 Day 2238.83
26 Day 2203.17
50 Day 2206.57
100 Day 2367.90
200 Day 2507.34
Deals & Announcements
Bulk and Block Deals
| Client Name | Deal Type | Action | Date | Avg. Price | Quantity | Exchange |
|---|---|---|---|---|---|---|
| ISHARES INDIA SC MAURITIUS COMPANY | block | Sell | 03 Oct, 2022 | ₹1,424.40 | 11,373 | NSE |
| ISHARES CORE EMERGING MARKETS MAURITIUS CO | block | Sell | 03 Oct, 2022 | ₹1,424.40 | 77,439 | NSE |
| ISHARES MSCI INDIA SMALL-CAP ETF | block | Buy | 03 Oct, 2022 | ₹1,424.40 | 11,373 | NSE |
| ISHARES CORE MSCI EMERGING MARKETS ETF | block | Buy | 03 Oct, 2022 | ₹1,424.40 | 77,439 | NSE |
Insider Trading
Corporate Actions
| Announcement Date | Subject | Ex - Date | Record Date |
|---|---|---|---|
| 24 Oct, 2024 | Rs.12.0000 per share(120%)Interim Dividend | 07 Nov, 2024 | 07 Nov, 2024 |
| 17 May, 2024 | Rs.32.0000 per share(320%)Final Dividend | 31 May, 2024 | 31 May, 2024 |
| 17 May, 2023 | Rs.32.0000 per share(320%)Final Dividend | 30 Jun, 2023 | 30 Jun, 2023 |
Announcements
| Date | Source | Detail |
|---|---|---|
| 04 Apr, 2025 | BSE India | As per attachment |
| 04 Apr, 2025 | BSE India | As per attachment |
| 31 Mar, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Copy of Newspaper Publication |
| 28 Mar, 2025 | NSE India | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Notice of Shareholders Meeting for Postal Ballot |
| 28 Mar, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about Shareholders meeting |
| 28 Mar, 2025 | BSE India | Postal Ballot Notice |
| 26 Mar, 2025 | NSE India | GLAXOSMITHKLINE PHARMACEUTICALS LIMITED has informed the Exchange about Change in Directors/ Key Managerial Personnel/ Auditor/ Compliance Officer/ Share Transfer Agent |
| 26 Mar, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange about change in Management |
| 26 Mar, 2025 | NSE India | GlaxoSmithKline Pharmaceuticals Limited has informed the Exchange regarding Board meeting held on March 26, 2025. |
| 26 Mar, 2025 | BSE India | Change in Directorate |
Board Meetings
| Purpose | Details | Meeting Date | Broadcast Date |
|---|---|---|---|
| Quarterly Results | (Revised) | 21 Jan, 2025 | 14 Feb, 2025 |
| Quarterly Results | (Cancelled) | 21 Jan, 2025 | 10 Feb, 2025 |
| Quarterly Results & Interim Dividend | -- | 25 Oct, 2024 | 29 Oct, 2024 |
| Quarterly Results | -- | 19 Jul, 2024 | 02 Aug, 2024 |
| Audited Results & Final Dividend | -- | 22 Apr, 2024 | 17 May, 2024 |
| Quarterly Results | -- | 05 Jan, 2024 | 12 Feb, 2024 |
| Quarterly Results | -- | 05 Oct, 2023 | 09 Nov, 2023 |
| Quarterly Results | -- | 03 Jul, 2023 | 26 Jul, 2023 |
| Audited Results & Final Dividend | -- | 04 May, 2023 | 17 May, 2023 |
| Quarterly Results | -- | 12 Jan, 2023 | 07 Feb, 2023 |
Share Holding Pattern
| Owner Name | Dec, 2024 | Dec, 2023 | Dec, 2022 | Dec, 2021 | Dec, 2020 |
|---|---|---|---|---|---|
| Promoter Group | 75% | 75% | 75% | 75% | 75% |
| Foreign Institutions + | 4.5% | 2.93% | 2.28% | 2.04% | 1.54% |
| Domestic Institutions + | 7.3% | 8.64% | 10.29% | 10.74% | 10.77% |
| Government | 0% | 0.01% | 0% | 0% | 0% |
| Public | 13.2% | 13.42% | 12.43% | 12.22% | 12.69% |
| Others | 0% | 0% | 0% | 0% | 0% |
About GlaxoSmithKline Pharmaceuticals
GlaxoSmithKline Pharmaceuticals is a Public Limited Listed company incorporated on 13/11/1924 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24239MH1924PLC001151 and registration number is 001151. Currently Company is involved in the business activities of Manufacture of allopathic pharmaceutical preparations. Company’s Total Operating Revenue is Rs. 3407.25 Cr. and Equity Capital is Rs. 169.41 Cr. for the Year ended 31/03/2024.
Parent Organisation
MNC Associate
Founded
1924
Managing Director
Mr. B Akshikar
NSE Symbol
GLAXO
GlaxoSmithKline Pharmaceuticals Management
| Name | Designation |
|---|---|
| Ms. R S Karnad | Chairperson |
| Mr. B Akshikar | Managing Director |
| Mr. J Chandy | WholeTime Director & CFO |
| Mr. S Williams | Non Executive Director |
| Mr. M Anand | Independent Director |
| Dr.(Ms.) S Maheshwari | Independent Director |
| Mr. A N Roy | Independent Director |
| Mr. D Sundaram | Independent Director |
| Mr. P V Bhide | Independent Director |
Peer Comparison
| Stocks | Market Cap | Market Price | 52 Week Low-High |
|---|---|---|---|
| Sun Pharmaceutical Industries | ₹4,10,130.32 | ₹1,709.35  ₹1,770.00(-3.43%) | ₹1,376.750 - ₹1,960.200 |
| Divi's Laboratories | ₹1,45,552.44 | ₹5,482.85 ₹5,763.00(-4.86%) | ₹3,613.550 - ₹6,448.750 |
| Cipla | ₹1,14,298.01 | ₹1,415.25 ₹1,495.70(-5.38%) | ₹1,317.600 - ₹1,702.000 |
| Torrent Pharmaceuticals | ₹1,11,230.09 | ₹3,286.50  ₹3,247.70(1.19%) | ₹2,508.650 - ₹3,589.950 |
| Mankind Pharma | ₹1,01,131.25 | ₹2,451.20 ₹2,427.70(0.97%) | ₹1,910.100 - ₹3,050.000 |
FAQs on GlaxoSmithKline Pharmaceuticals
What is the share price of GlaxoSmithKline Pharmaceuticals?
The share price of GlaxoSmithKline Pharmaceuticals on 04 Apr, 2025 is ₹ 2,739.25.
What is 52W high and 52W low share price of GlaxoSmithKline Pharmaceuticals?
The highest and lowest 52W share prices of GlaxoSmithKline Pharmaceuticals are ₹ 3087.950 and ₹ 1825.050
What is the market cap of GlaxoSmithKline Pharmaceuticals?
The market capitalization of GlaxoSmithKline Pharmaceuticals as of 04 Apr, 2025 is ₹ 46,404.55 Crores
What is the P/E ratio of GlaxoSmithKline Pharmaceuticals?
The current P/E ratio of GlaxoSmithKline Pharmaceuticals as of 04 Apr, 2025 is 44.73
What is the PB ratio of GlaxoSmithKline Pharmaceuticals?
The PB ratio of GlaxoSmithKline Pharmaceuticals as of 04 Apr, 2025 is 26.11
Top Gainers
₹18.07
₹15.14 (0.19%)
₹66.60
₹57.80 (0.15%)
₹88.74
₹73.95 (0.20%)
₹197.50
₹167.35 (0.18%)
Top Losers
₹307.35
₹368.55 (-0.17%)
₹108.20
₹127.00 (-0.15%)
₹0.54
₹1.03 (-0.48%)
₹2,705.55
₹3,206.90 (-0.16%)
Market Indices
Sensex
₹75,364.69
₹76,295.36 (-0.01%)